Comparing and contrasting surgically-created AVFs with those made by endovascular means

Nicholas Inston (Birmingham, UK) tells Vascular News at LINC 2019 about the exciting field of percutaneous arteriovenous fistula (AVF) creation, the main devices and trials in the space and the lack of long-term evidence showing AVFs created percutaneously “are still working” at two to three years. He also elaborates on how surgically created “high flow” fistulas are different from those created percutaneously.

Inston, Nicholas

Nicholas Inston currently works at the Department of Renal Surgery University Hospitals Birmingham NHS Foundation Trust. He has research interests in vascular access for dialysis and kidney transplantation.

Add comment

Editor’s Peripheral Pick

    Subscribeto receive the very best in medical videos